N@N

Market Maker Surveillance Report. OXIS, GILD, CALD, POM, BBT, SPLS, Bearishly Biased Price Friction For Wednesday, May 18th 20

^{Published on 2011-05-18 17:50:56 - WOPRAI}
 

May 18, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 2490 companies with "abnormal" market making, 3614 companies with positive Friction Factors and 1497 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bearish bias) in their stock prices. This means that there was more buying than selling in the stocks and their stock prices dropped. OXIS INTERNATIONAL INC (OTC:OXIS), GILEAD SCIENCES INC (NASDAQ:GILD), CALLIDUS SOFTWARE INC (NASDAQ:CALD), PEPCO HOLDINGS INC (NYSE:POM), BB&T CORP (NYSE:BBT), STAPLES INC (NASDAQ:SPLS). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     OXIS       $-0.017      -17.35%      1,101,254       89.04%       135,500         10.96%       965,754         Abnormal
     GILD       $-0.080      -0.20%       4,443,654       55.60%       3,554,475       44.47%       889,179         Abnormal
     CALD       $-0.020      -0.32%       3,844,095       79.11%       1,227,015       25.25%       2,617,080       Abnormal
     POM        $-0.070      -0.35%       1,386,523       61.32%       489,833         21.66%       896,690         Abnormal
     BBT        $-0.040      -0.17%       2,599,183       43.23%       1,650,255       27.44%       948,928         Abnormal
     SPLS       $-2.970      -15.11%      33,604,202      53.93%       27,961,619      44.87%       5,642,583       Abnormal

For example, the chart above shows OXIS with 965,754 greater shares of buying than selling (NetVol) and the stock price was down $-0.01700. This means the Market Makers were trading the stock in a way inconsistent with normal supply and demand (Economics 101); more buying than selling should cause prices to rise.

OXIS INTERNATIONAL INC (OTC:OXIS) - OXIS International, Inc. engages in the research, development, and marketing of nutraceutical and cosmeceutical products in the field of oxidative stress reduction and inflammation. The company primarily focuses on developing a line of dietary supplements containing L-Ergothioneine (ERGO). ERGO is naturally occurring, water soluble, and amino acid antioxidant produced by microbes in the soil and found in various species of mushrooms and grapes, meats, and dairy products. It offers Ergo-Plex, a dietary supplement for the maintenance of joint health. The company also holds patents and patent applications for the protection of ERGO on mitochondria, the ERGO manufacturing process, and the neuroprotectant methods and compositions of ERGO. OXIS International, Inc. was founded in 1965 and is based in Beverly Hills, California.

GILEAD SCIENCES INC (NASDAQ:GILD) - Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. Its products include Atripla, Truvada, Viread, Emtriva for the treatment of human immunodeficiency virus infection in adults; Hepsera, an oral formulation for the treatment of chronic hepatitis B; AmBisome, a amphotericin B liposome injection to treat invasive fungal infections; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa for the treatment of chronic angina; Vistide, an antiviral medication for the treatment of cytomegalovirus retinitis in patients with AIDS; and Cayston, an inhaled antibiotic used as a treatment to enhance respiratory systems. The companys products also comprise Tamiflu, an oral antiviral for the treatment and prevention of influenza A and B; Macugen, an intravitreal injection for the treatment of neovascular age-related macular degeneration; and Lexiscan/Rapiscan, an injection used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging. Its products under the Phase III clinical trials consist of Cobicistat, a pharmacoenhancer that is under evaluation as a boosting agent for HIV medicines; Elvitegravir, an oral integrase inhibitor being evaluated as part of combination therapy for HIV; Integrase Single-Tablet, a Quad regimen of elvitegravir, cobicistat, tenofovir disoproxil fumarate, and emtricitabine for the treatment of HIV/AIDS in treatment-naive patients; and Aztreonam for inhalation solution for the treatment of cystic fibrosis patients with Pseudomonas aeruginosa. The companys Phase II clinical trials products comprise Cicletanine, Ranolazine, and Aztreonam, as well as GS 9190, GS 9256, and GS 9451. Its Phase I clinical trial products include GS 7340, GS 5885, GS 6620, GS 9620, and GS 6624. The company was founded in 1987 and is headquartered in Foster City, California.

CALLIDUS SOFTWARE INC (NASDAQ:CALD) - Callidus Software Inc. provides sales performance management (SPM) software and services. Its SPM systems are used to monitor and analyze sales performance and incentive compensation management programs. The companys products include TrueComp Manager Application, which automates the modeling, design, administration, reporting, and analysis of pay-for-performance programs; Callidus Reporting that delivers real-time production reports; Callidus Analytics, which enables businesses to deploy performance dashboards across the sales force and selling channels; Callidus Producer Management for insurance carriers; and Callidus Channel Management for telecommunications companies to view and update dealer information. Its products also comprise Callidus Objective Management that enables organizations to design and deploy pay-for-performance initiatives; Callidus Quota Management to provide sales and finance teams with a solution that ensures sales quotas; Callidus Communicator, which accelerates and streamlines communications with a business sales force and channels; Callidus Business Process Management that provides a configurable, template-based platform to define, model, build, deploy, and optimize workflows for critical sales and operational processes; Callidus Commissions Manager for sales professionals; and Callidus Plan Communicator, which accelerates the process of rolling out and communicating incentive plans across the sales force. In addition, the company provides professional, maintenance and technical support, and professional development services. It serves telecommunications, insurance, banking, technology, life sciences, pharmaceuticals, and retail and distribution markets. The company has strategic alliances with Accenture and salesforce.com. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was founded in 1996 and is headquartered in Pleasanton, California.

PEPCO HOLDINGS INC (NYSE:POM) - Pepco Holdings, Inc. operates as a diversified energy company. It operates in two divisions, Power Delivery and Competitive Energy. The Power Delivery division engages in the transmission, distribution, and supply of electricity; and the delivery and supply of natural gas. This division owns and operates a network of transmission or distribution facilities comprising wires, substations, and other equipment. As of December 31, 2009, it delivered electricity to approximately 1.8 million customers in the mid-Atlantic region and distributed natural gas to approximately 123,000 customers in Delaware. The Competitive Energy division involves in the competitive generation, marketing, and supply of electricity and natural gas; and provision of related energy management services primarily in the mid-Atlantic region. It provides wholesale electric power, capacity, and ancillary services in the wholesale markets and supplies electricity to other wholesale market participants under long and short-term bilateral contracts. This division owned and operated mid-merit plants with a combined 2,250 megawatts (MW) of capacity, peak-load plants with a combined 722 MW of capacity, and base-load generating plants with a combined 340 MW of capacity. It also provides energy savings performance contracting services to federal, state, and local government customers, as well as retail energy supply services to commercial, industrial, and government customers; and designs, constructs, and operates combined heat and power plants, and central energy plants. In addition, this division offers high and low voltage electric construction and maintenance services; and streetlight construction and asset management services to utilities, municipalities, and other customers in the Washington, D.C. area. Further, it owned 3 landfill gas-fired electricity plants with a total generating capacity of 10 MW. The company was founded in 1896 and is based in Washington, District of Columbia.

BB&T CORP (NYSE:BBT) - BB&T Corporation operates as the financial holding company for Branch Banking and Trust Company that provides banking and trust services to small and mid-size businesses, public agencies, local governments, and individuals in the United States. It accepts various deposit products, including noninterest-bearing checking accounts, interest-bearing checking accounts, savings accounts, money rate savings accounts, certificates of deposit, and individual retirement accounts. The companys loan portfolio includes commercial, financial, and agricultural loans; real estate construction and land development, and mortgage loans; and consumer loans. BB&T Corporation, through its other subsidiaries, offers bankcard lending, consumer finance, home equity lending, home mortgage lending, insurance, investment brokerage services, payment solutions, sales finance, small business lending, and wealth management/private banking services to retail clients; and asset management, association services, capital markets services, commercial finance, commercial middle market lending, commercial mortgage lending, institutional trust services, insurance, insurance premium finance, international banking services, leasing, merchant services, mortgage warehouse lending, real estate lending, supply chain management, and venture capital services to commercial clients. As of December 31, 2009, it operated 1,857 banking offices in North Carolina, Virginia, Florida, Georgia, Maryland, South Carolina, Alabama, Kentucky, West Virginia, Tennessee, Texas, Washington D.C., and Indiana. The company was founded in 1906 and is headquartered in Winston-Salem, North Carolina.

STAPLES INC (NASDAQ:SPLS) - Staples, Inc., together with its subsidiaries, operates as an office products company. The company sells various office supplies and services, business machines and related products, computers and related products, and office furniture. It also provides high-speed, color and self-service copying, other printing services, faxing, and pack and ship services. As of January 30, 2010, the company operated approximately 2,243 superstores in 48 states and the District of Columbia in the United States, and 10 provinces and 2 territories in Canada, as well as in Belgium, Denmark, Germany, Ireland, the Netherlands, Norway, Portugal, Sweden, the United Kingdom, the People's Republic of China, Argentina, and Australia. It also operated 125 distribution and fulfillment centers in 29 states in the United States and 8 provinces in Canada, as well as in Austria, Belgium, Denmark, France, Germany, Ireland, Italy, the Netherlands, Norway, Poland, Portugal, Spain, Sweden, the United Kingdom, the People's Republic of China, Argentina, Brazil, and Australia. The company also offers its products through catalogs, Internet, and sales force. Staples, Inc. was founded in 1986 and is based in Framingham, Massachusetts.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net